SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-22-020169
Filing Date
2022-10-03
Accepted
2022-10-03 17:18:43
Documents
2
Period of Report
2022-09-29

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 2077
2 POWER OF ATTORNEY exhibit24.txt EX-24 2924
  Complete submission text file 0001062993-22-020169.txt   6701
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Issuer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMICUS THERAPEUTICS, INC. 6 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Dentzer James E (Reporting) CIK: 0001400977 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15911 | Film No.: 221288604